Two Sigma Investments’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-578,782
| Closed | -$26.8M | – | 3991 |
|
|
2019
Q2 | $26.8M | Sell |
578,782
-607,657
| -51% | -$17.1M | 0.09% | 292 |
|
|
2019
Q1 | $28.9M | Buy |
+1,186,439
| New | +$24.7M | 0.09% | 282 |
|
|
2018
Q2 | – | Sell |
-412,582
| Closed | -$6.73M | – | 3839 |
|
|
2018
Q1 | $6.73M | Sell |
412,582
-657,355
| -61% | -$10.5M | 0.02% | 786 |
|
|
2017
Q4 | $13.7M | Sell |
1,069,937
-1,143,781
| -52% | -$13M | 0.04% | 485 |
|
|
2017
Q3 | $27.2M | Buy |
2,213,718
+1,632,709
| +281% | +$15.2M | 0.1% | 261 |
|
|
2017
Q2 | $4.86M | Sell |
581,009
-1,701,591
| -75% | -$13.9M | 0.02% | 870 |
|
|
2017
Q1 | $20.4M | Buy |
+2,282,600
| New | +$24.3M | 0.07% | 369 |
|
|
2016
Q4 | – | Sell |
-450,229
| Closed | -$3.04M | – | 3672 |
|
|
2016
Q3 | $3.04M | Buy |
+450,229
| New | +$1.74M | 0.01% | 1182 |
|
|
2016
Q1 | – | Sell |
-205,654
| Closed | -$868K | – | 3269 |
|
|
2015
Q4 | $868K | Buy |
205,654
+84,297
| +69% | +$385K | ﹤0.01% | 1604 |
|
|
2015
Q3 | $553K | Sell |
121,357
-888,918
| -88% | -$5.27M | ﹤0.01% | 1493 |
|
|
2015
Q2 | $7.28M | Buy |
1,010,275
+195,412
| +24% | +$1.44M | 0.03% | 553 |
|
|
2015
Q1 | $6.01M | Buy |
814,863
+452,744
| +125% | +$3.22M | 0.03% | 651 |
|
|
2014
Q4 | $1.71M | Buy |
+362,119
| New | +$1.43M | 0.01% | 1091 |
|
|
2014
Q1 | – | Sell |
-187,453
| Closed | -$939K | – | 2400 |
|
|
2013
Q4 | $939K | Buy |
+187,453
| New | +$1.02M | 0.01% | 1357 |
|
Other funds holding ARRY
Two Sigma Investments's ARRY Position: Q3 2019 in Review
Two Sigma Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 578,782 shares — an estimated $26.8M sold.
Two Sigma Investments first reported a position in ARRY in Q4 2013 and held it in 14 quarters. The position peaked at $28.9M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Two Sigma Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Two Sigma Investments sold 578,782 Array Biopharma Inc shares in Q3 2019, an estimated $26.8M.
- Two Sigma Investments first reported a position in Array Biopharma Inc in Q4 2013 and held it in 14 quarters.
- Two Sigma Investments's Array Biopharma Inc position peaked at $28.9M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Two Sigma Investments's 13F filing for Q3 2019, filed 14 Nov 2019.